Global and United States Diphtheria Vaccine Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 126
Inquire Before Buying

Diphtheria Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Diphtheria Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Diphtheria Vaccine market is segmented into

- DTaP

- DT

- Td

- Tdap

Segment by Application, the Diphtheria Vaccine market is segmented into

- For infants and children younger than seven years of age

- For adolescents and adults

Regional and Country-level Analysis

The Diphtheria Vaccine market is analysed and market size information is provided by regions (countries).

The key regions covered in the Diphtheria Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Diphtheria Vaccine Market Share Analysis

Diphtheria Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Diphtheria Vaccine business, the date to enter into the Diphtheria Vaccine market, Diphtheria Vaccine product introduction, recent developments, etc.

The major vendors covered:

- GlaxoSmithKline

- Sanofi Pasteur

- Wyeth (Pfizer)

- Merck

- Novartis

- Beijing Tiantan Biological Products

- Shanghai Institute of Biological Products

- Wuhan Institute of Biological Products

- Chengdu Institute of Biological Products

- Changchun Changsheng Life Sciences

Global and United States Diphtheria Vaccine Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Diphtheria Vaccine Product Introduction
1.2 Market Segments
1.3 Key Diphtheria Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Diphtheria Vaccine Market Size Growth Rate by Type
1.4.2 DTaP
1.4.3 DT
1.4.4 Td
1.4.5 Tdap
1.5 Market by Application
1.5.1 Global Diphtheria Vaccine Market Size Growth Rate by Application
1.5.2 For infants and children younger than seven years of age
1.5.3 For adolescents and adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Diphtheria Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Diphtheria Vaccine Revenue 2015-2026
2.1.2 Global Diphtheria Vaccine Sales 2015-2026
2.2 Global Diphtheria Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Diphtheria Vaccine Historical Market Size by Region (2015-2020)
2.3.1 Global Diphtheria Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Diphtheria Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Diphtheria Vaccine Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Diphtheria Vaccine Sales Forecast by Region (2021-2026)
2.4.2 Global Diphtheria Vaccine Revenue Forecast by Region (2021-2026)
3 Global Diphtheria Vaccine Competitor Landscape by Players
3.1 Global Top Diphtheria Vaccine Sales by Manufacturers
3.1.1 Global Diphtheria Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global Diphtheria Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Global Diphtheria Vaccine Manufacturers by Revenue
3.2.1 Global Diphtheria Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global Diphtheria Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Diphtheria Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Diphtheria Vaccine Revenue in 2019
3.2.5 Global Diphtheria Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Diphtheria Vaccine Price by Manufacturers
3.4 Global Diphtheria Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Diphtheria Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Diphtheria Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Diphtheria Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diphtheria Vaccine Market Size by Type (2015-2020)
4.1.1 Global Diphtheria Vaccine Sales by Type (2015-2020)
4.1.2 Global Diphtheria Vaccine Revenue by Type (2015-2020)
4.1.3 Diphtheria Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Diphtheria Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Diphtheria Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Diphtheria Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Diphtheria Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Diphtheria Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Diphtheria Vaccine Market Size by Application (2015-2020)
5.1.1 Global Diphtheria Vaccine Sales by Application (2015-2020)
5.1.2 Global Diphtheria Vaccine Revenue by Application (2015-2020)
5.1.3 Diphtheria Vaccine Price by Application (2015-2020)
5.2 Diphtheria Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Diphtheria Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Diphtheria Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Diphtheria Vaccine Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Diphtheria Vaccine Market Size YoY Growth 2015-2026
6.1.1 United States Diphtheria Vaccine Sales YoY Growth 2015-2026
6.1.2 United States Diphtheria Vaccine Revenue YoY Growth 2015-2026
6.1.3 United States Diphtheria Vaccine Market Share in Global Market 2015-2026
6.2 United States Diphtheria Vaccine Market Size by Players (International and Local Players)
6.2.1 United States Top Diphtheria Vaccine Players by Sales (2015-2020)
6.2.2 United States Top Diphtheria Vaccine Players by Revenue (2015-2020)
6.3 United States Diphtheria Vaccine Historic Market Review by Type (2015-2020)
6.3.1 United States Diphtheria Vaccine Sales Market Share by Type (2015-2020)
6.3.2 United States Diphtheria Vaccine Revenue Market Share by Type (2015-2020)
6.3.3 United States Diphtheria Vaccine Price by Type (2015-2020)
6.4 United States Diphtheria Vaccine Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Diphtheria Vaccine Sales Forecast by Type (2021-2026)
6.4.2 United States Diphtheria Vaccine Revenue Forecast by Type (2021-2026)
6.4.3 United States Diphtheria Vaccine Price Forecast by Type (2021-2026)
6.5 United States Diphtheria Vaccine Historic Market Review by Application (2015-2020)
6.5.1 United States Diphtheria Vaccine Sales Market Share by Application (2015-2020)
6.5.2 United States Diphtheria Vaccine Revenue Market Share by Application (2015-2020)
6.5.3 United States Diphtheria Vaccine Price by Application (2015-2020)
6.6 United States Diphtheria Vaccine Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Diphtheria Vaccine Sales Forecast by Application (2021-2026)
6.6.2 United States Diphtheria Vaccine Revenue Forecast by Application (2021-2026)
6.6.3 United States Diphtheria Vaccine Price Forecast by Application (2021-2026)
7 North America
7.1 North America Diphtheria Vaccine Market Size YoY Growth 2015-2026
7.2 North America Diphtheria Vaccine Market Facts & Figures by Country
7.2.1 North America Diphtheria Vaccine Sales by Country (2015-2020)
7.2.2 North America Diphtheria Vaccine Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Diphtheria Vaccine Market Size YoY Growth 2015-2026
8.2 Europe Diphtheria Vaccine Market Facts & Figures by Country
8.2.1 Europe Diphtheria Vaccine Sales by Country
8.2.2 Europe Diphtheria Vaccine Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Diphtheria Vaccine Market Size YoY Growth 2015-2026
9.2 Asia Pacific Diphtheria Vaccine Market Facts & Figures by Country
9.2.1 Asia Pacific Diphtheria Vaccine Sales by Region (2015-2020)
9.2.2 Asia Pacific Diphtheria Vaccine Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Diphtheria Vaccine Market Size YoY Growth 2015-2026
10.2 Latin America Diphtheria Vaccine Market Facts & Figures by Country
10.2.1 Latin America Diphtheria Vaccine Sales by Country
10.2.2 Latin America Diphtheria Vaccine Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diphtheria Vaccine Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Diphtheria Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Diphtheria Vaccine Sales by Country
11.2.2 Middle East and Africa Diphtheria Vaccine Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Diphtheria Vaccine Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Sanofi Pasteur
12.2.1 Sanofi Pasteur Corporation Information
12.2.2 Sanofi Pasteur Description and Business Overview
12.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pasteur Diphtheria Vaccine Products Offered
12.2.5 Sanofi Pasteur Recent Development
12.3 Wyeth (Pfizer)
12.3.1 Wyeth (Pfizer) Corporation Information
12.3.2 Wyeth (Pfizer) Description and Business Overview
12.3.3 Wyeth (Pfizer) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Wyeth (Pfizer) Diphtheria Vaccine Products Offered
12.3.5 Wyeth (Pfizer) Recent Development
12.4 Merck
12.4.1 Merck Corporation Information
12.4.2 Merck Description and Business Overview
12.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Diphtheria Vaccine Products Offered
12.4.5 Merck Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Diphtheria Vaccine Products Offered
12.5.5 Novartis Recent Development
12.6 Beijing Tiantan Biological Products
12.6.1 Beijing Tiantan Biological Products Corporation Information
12.6.2 Beijing Tiantan Biological Products Description and Business Overview
12.6.3 Beijing Tiantan Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Beijing Tiantan Biological Products Diphtheria Vaccine Products Offered
12.6.5 Beijing Tiantan Biological Products Recent Development
12.7 Shanghai Institute of Biological Products
12.7.1 Shanghai Institute of Biological Products Corporation Information
12.7.2 Shanghai Institute of Biological Products Description and Business Overview
12.7.3 Shanghai Institute of Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Shanghai Institute of Biological Products Diphtheria Vaccine Products Offered
12.7.5 Shanghai Institute of Biological Products Recent Development
12.8 Wuhan Institute of Biological Products
12.8.1 Wuhan Institute of Biological Products Corporation Information
12.8.2 Wuhan Institute of Biological Products Description and Business Overview
12.8.3 Wuhan Institute of Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Wuhan Institute of Biological Products Diphtheria Vaccine Products Offered
12.8.5 Wuhan Institute of Biological Products Recent Development
12.9 Chengdu Institute of Biological Products
12.9.1 Chengdu Institute of Biological Products Corporation Information
12.9.2 Chengdu Institute of Biological Products Description and Business Overview
12.9.3 Chengdu Institute of Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Chengdu Institute of Biological Products Diphtheria Vaccine Products Offered
12.9.5 Chengdu Institute of Biological Products Recent Development
12.10 Changchun Changsheng Life Sciences
12.10.1 Changchun Changsheng Life Sciences Corporation Information
12.10.2 Changchun Changsheng Life Sciences Description and Business Overview
12.10.3 Changchun Changsheng Life Sciences Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Changchun Changsheng Life Sciences Diphtheria Vaccine Products Offered
12.10.5 Changchun Changsheng Life Sciences Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Diphtheria Vaccine Products Offered
12.11.5 GlaxoSmithKline Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Diphtheria Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Diphtheria Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Diphtheria Vaccine Market Segments
Table 2. Ranking of Global Top Diphtheria Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Diphtheria Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of DTaP
Table 5. Major Manufacturers of DT
Table 6. Major Manufacturers of Td
Table 7. Major Manufacturers of Tdap
Table 8. Global Diphtheria Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 9. Global Diphtheria Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 10. Global Diphtheria Vaccine Sales by Regions 2015-2020 (K Doses)
Table 11. Global Diphtheria Vaccine Sales Market Share by Regions (2015-2020)
Table 12. Global Diphtheria Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Diphtheria Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 14. Global Diphtheria Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 15. Global Diphtheria Vaccine Sales Share by Manufacturers (2015-2020)
Table 16. Global Diphtheria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Diphtheria Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diphtheria Vaccine as of 2019)
Table 18. Diphtheria Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Diphtheria Vaccine Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Diphtheria Vaccine Price (2015-2020) (USD/Dose)
Table 21. Diphtheria Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Diphtheria Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Diphtheria Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Diphtheria Vaccine Sales by Type (2015-2020) (K Doses)
Table 26. Global Diphtheria Vaccine Sales Share by Type (2015-2020)
Table 27. Global Diphtheria Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Diphtheria Vaccine Revenue Share by Type (2015-2020)
Table 29. Diphtheria Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 30. Global Diphtheria Vaccine Sales Share by Type (2021-2026)
Table 31. Global Diphtheria Vaccine Sales by Application (2015-2020) (K Doses)
Table 32. Global Diphtheria Vaccine Sales Share by Application (2015-2020)
Table 33. Global Diphtheria Vaccine Sales Share by Application (2021-2026)
Table 34. Global Diphtheria Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Diphtheria Vaccine Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Diphtheria Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 37. United States Diphtheria Vaccine Sales (K Doses) of Key Companies (2015-2020)
Table 38. United States Diphtheria Vaccine Sales Share by Company (2015-2020)
Table 39. United States Diphtheria Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 40. United States Diphtheria Vaccine Sales (K Doses) by Type (2015-2020)
Table 41. United States Diphtheria Vaccine Sales Share by Type (2015-2020)
Table 42. United States Diphtheria Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. United States Diphtheria Vaccine Price (K Doses) by Type (2015-2020)
Table 44. United States Diphtheria Vaccine Sales (K Doses) by Type (2021-2026)
Table 45. United States Diphtheria Vaccine Sales Share by Type (2021-2026)
Table 46. United States Diphtheria Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. United States Diphtheria Vaccine Revenue Share by Type (2021-2026)
Table 48. United States Diphtheria Vaccine Price (K Doses) by Type (2021-2026)
Table 49. United States Diphtheria Vaccine Sales (K Doses) by Application (2015-2020)
Table 50. United States Diphtheria Vaccine Sales Share by Application (2015-2020)
Table 51. United States Diphtheria Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. United States Diphtheria Vaccine Sales (K Doses) by Application (2021-2026)
Table 53. United States Diphtheria Vaccine Sales Share by Application (2021-2026)
Table 54. United States Diphtheria Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. United States Diphtheria Vaccine Revenue Share by Application (2021-2026)
Table 56. North America Diphtheria Vaccine Sales by Country (2015-2020) (K Doses)
Table 57. North America Diphtheria Vaccine Sales Market Share by Country (2015-2020)
Table 58. North America Diphtheria Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Diphtheria Vaccine Revenue Market Share by Country (2015-2020)
Table 60. Europe Diphtheria Vaccine Sales by Country (2015-2020) (K Doses)
Table 61. Europe Diphtheria Vaccine Sales Market Share by Country (2015-2020)
Table 62. Europe Diphtheria Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Diphtheria Vaccine Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Diphtheria Vaccine Sales by Region (2015-2020) (K Doses)
Table 65. Asia Pacific Diphtheria Vaccine Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Diphtheria Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Diphtheria Vaccine Revenue Market Share by Region (2015-2020)
Table 68. Latin America Diphtheria Vaccine Sales by Country (2015-2020) (K Doses)
Table 69. Latin America Diphtheria Vaccine Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Diphtheria Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Diphtheria Vaccine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Diphtheria Vaccine Sales by Country (2015-2020) (K Doses)
Table 73. Middle East and Africa Diphtheria Vaccine Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Diphtheria Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Diphtheria Vaccine Revenue Market Share by Country (2015-2020)
Table 76. GlaxoSmithKline Corporation Information
Table 77. GlaxoSmithKline Description and Business Overview
Table 78. GlaxoSmithKline Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 79. GlaxoSmithKline Diphtheria Vaccine Product
Table 80. GlaxoSmithKline Recent Development
Table 81. Sanofi Pasteur Corporation Information
Table 82. Sanofi Pasteur Description and Business Overview
Table 83. Sanofi Pasteur Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 84. Sanofi Pasteur Product
Table 85. Sanofi Pasteur Recent Development
Table 86. Wyeth (Pfizer) Corporation Information
Table 87. Wyeth (Pfizer) Description and Business Overview
Table 88. Wyeth (Pfizer) Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 89. Wyeth (Pfizer) Product
Table 90. Wyeth (Pfizer) Recent Development
Table 91. Merck Corporation Information
Table 92. Merck Description and Business Overview
Table 93. Merck Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 94. Merck Product
Table 95. Merck Recent Development
Table 96. Novartis Corporation Information
Table 97. Novartis Description and Business Overview
Table 98. Novartis Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 99. Novartis Product
Table 100. Novartis Recent Development
Table 101. Beijing Tiantan Biological Products Corporation Information
Table 102. Beijing Tiantan Biological Products Description and Business Overview
Table 103. Beijing Tiantan Biological Products Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 104. Beijing Tiantan Biological Products Product
Table 105. Beijing Tiantan Biological Products Recent Development
Table 106. Shanghai Institute of Biological Products Corporation Information
Table 107. Shanghai Institute of Biological Products Description and Business Overview
Table 108. Shanghai Institute of Biological Products Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 109. Shanghai Institute of Biological Products Product
Table 110. Shanghai Institute of Biological Products Recent Development
Table 111. Wuhan Institute of Biological Products Corporation Information
Table 112. Wuhan Institute of Biological Products Description and Business Overview
Table 113. Wuhan Institute of Biological Products Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 114. Wuhan Institute of Biological Products Product
Table 115. Wuhan Institute of Biological Products Recent Development
Table 116. Chengdu Institute of Biological Products Corporation Information
Table 117. Chengdu Institute of Biological Products Description and Business Overview
Table 118. Chengdu Institute of Biological Products Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 119. Chengdu Institute of Biological Products Product
Table 120. Chengdu Institute of Biological Products Recent Development
Table 121. Changchun Changsheng Life Sciences Corporation Information
Table 122. Changchun Changsheng Life Sciences Description and Business Overview
Table 123. Changchun Changsheng Life Sciences Diphtheria Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 124. Changchun Changsheng Life Sciences Product
Table 125. Changchun Changsheng Life Sciences Recent Development
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Diphtheria Vaccine Players
Table 130. Diphtheria Vaccine Customers List
Table 131. Diphtheria Vaccine Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria Vaccine Product Picture
Figure 2. Global Diphtheria Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. DTaP Product Picture
Figure 4. DT Product Picture
Figure 5. Td Product Picture
Figure 6. Tdap Product Picture
Figure 7. Global Diphtheria Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. For infants and children younger than seven years of age
Figure 9. For adolescents and adults
Figure 10. Diphtheria Vaccine Report Years Considered
Figure 11. Global Diphtheria Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Diphtheria Vaccine Sales 2015-2026 (K Doses)
Figure 13. Global Diphtheria Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Diphtheria Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Diphtheria Vaccine Sales Market Share by Region in 2019
Figure 16. Global Diphtheria Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Diphtheria Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Diphtheria Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Diphtheria Vaccine Revenue in 2019
Figure 20. Diphtheria Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Diphtheria Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Diphtheria Vaccine Sales Market Share by Type in 2019
Figure 23. Global Diphtheria Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Diphtheria Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Diphtheria Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Diphtheria Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Diphtheria Vaccine Sales Market Share by Application in 2019
Figure 28. Global Diphtheria Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Diphtheria Vaccine Revenue Market Share by Application in 2019
Figure 30. United States Diphtheria Vaccine Sales Growth Rate 2015-2026 (K Doses)
Figure 31. United States Diphtheria Vaccine Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. United States Diphtheria Vaccine Market Share in Global Market 2015-2026
Figure 33. United States 5 and 10 Largest Diphtheria Vaccine Players Market Share by Revenue in Diphtheria Vaccine in 2019
Figure 34. United States Diphtheria Vaccine Revenue Share by Type (2015-2020)
Figure 35. United States Diphtheria Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 36. United States Diphtheria Vaccine Revenue Share by Application (2015-2020)
Figure 37. United States Diphtheria Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Diphtheria Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. North America Diphtheria Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Diphtheria Vaccine Sales Market Share by Country in 2019
Figure 41. North America Diphtheria Vaccine Revenue Market Share by Country in 2019
Figure 42. U.S. Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. U.S. Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Canada Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Diphtheria Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 47. Europe Diphtheria Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Diphtheria Vaccine Sales Market Share by Country in 2019
Figure 49. Europe Diphtheria Vaccine Revenue Market Share by Country in 2019
Figure 50. Germany Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Germany Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. France Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 55. U.K. Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Diphtheria Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Diphtheria Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Diphtheria Vaccine Sales Market Share by Region in 2019
Figure 63. Asia Pacific Diphtheria Vaccine Revenue Market Share by Region in 2019
Figure 64. China Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Diphtheria Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 87. Latin America Diphtheria Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Diphtheria Vaccine Sales Market Share by Country in 2019
Figure 89. Latin America Diphtheria Vaccine Revenue Market Share by Country in 2019
Figure 90. Mexico Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Mexico Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Brazil Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Argentina Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Diphtheria Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Diphtheria Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Diphtheria Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Diphtheria Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Diphtheria Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Diphtheria Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Diphtheria Vaccine Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 146
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 142
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 126
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Protein Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 26-Oct-2020        Price: US 4860 Onwards        Pages: 103
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Protein Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related reg......
  • (Post-pandemic Era) - Global Protein Drugs Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 134
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Protein Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 138
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Oral Vaccines Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 26-Oct-2020        Price: US 4860 Onwards        Pages: 107
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Oral Vaccines growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related reg......
  • (Post-pandemic Era) - Global Oral Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 135
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Oral Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 135
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs